
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | -- | -- |
08/20/2025 | Q2 | $6.3M | -- | -- | -- | -- |
05/16/2025 | Q1 | $6.1M | $6.2M | -$0.69 | -- | -- |
03/31/2025 | Q4 | -- | $13.4M | -$0.79 | -- | -- |
11/14/2024 | Q3 | $4.6M | $7.8M | -$0.55 | -- | -- |
08/20/2024 | Q2 | $4.4M | $4M | -$0.52 | -- | -- |
05/20/2024 | Q1 | $12M | $3.4M | -$0.71 | -- | -- |
03/28/2024 | Q4 | $9.4M | $6.9M | -$0.46 | -$0.24 | -$0.22 |
11/01/2023 | Q3 | -- | -- | -$0.35 | -- | -- |
08/01/2023 | Q2 | -- | -- | -$0.77 | -$0.50 | -$0.27 |
03/31/2023 | Q1 | -- | -- | -$0.45 | -- | -- |
03/28/2023 | Q4 | -- | -- | -$1.44 | -- | -- |
11/11/2022 | Q3 | -- | -- | -$0.38 | -$0.38 | -- |
08/12/2022 | Q2 | -- | -- | -$0.56 | -$0.61 | $0.05 |
05/12/2022 | Q1 | -- | -- | -$0.62 | -- | -- |
03/28/2022 | Q4 | -- | -- | -$0.39 | -- | -- |
11/12/2021 | Q3 | -- | -- | -$0.73 | -- | -- |
08/12/2021 | Q2 | -- | -- | -$0.50 | -- | -- |
05/13/2021 | Q1 | -- | -- | -$1.10 | -- | -- |
03/30/2021 | Q4 | -- | -- | -$1.17 | -- | -- |
11/09/2020 | Q3 | -- | -- | -$1.40 | -- | -- |
08/10/2020 | Q2 | -- | -- | -$0.90 | -- | -- |
05/11/2020 | Q1 | -- | -- | -$0.90 | -- | -- |
03/16/2020 | Q4 | -- | -- | -$1.30 | -- | -- |
11/12/2019 | Q3 | -- | -- | -$1.00 | -- | -- |
08/09/2019 | Q2 | -- | -- | -$1.60 | -- | -- |
05/15/2019 | Q1 | -- | -- | -$0.90 | -- | -- |
03/29/2019 | Q4 | -- | -- | -$1.00 | -- | -- |
11/14/2018 | Q3 | -- | -- | -$1.00 | -- | -- |
08/14/2018 | Q2 | -- | -- | -$0.70 | -- | -- |
05/15/2018 | Q1 | -- | -- | -$0.50 | -- | -- |
03/29/2018 | Q4 | -- | -- | -$0.80 | -- | -- |
11/14/2017 | Q3 | -- | -- | -$0.30 | -- | -- |
08/14/2017 | Q2 | -- | -- | -$0.40 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.30 | -- | -- |
03/31/2017 | Q4 | -- | -- | -$0.44 | -- | -- |
11/14/2016 | Q3 | -- | -- | -$0.30 | -- | -- |
08/15/2016 | Q2 | -- | -- | -$0.80 | -- | -- |
05/13/2016 | Q1 | -- | -- | -$0.40 | -- | -- |
03/28/2016 | Q4 | -- | -- | -$0.50 | -- | -- |
11/13/2015 | Q3 | -- | -- | -$0.50 | -- | -- |
CASI Pharmaceuticals reported $6.2M worth of top line sales in its most recent quarter.
CASI Pharmaceuticals announced earnings per share of -$0.69 which represents a miss of analyst forecast a -- per share.
CASI Pharmaceuticals reported $3.6M that represents $0.23 per share over the last quarter.
CASI Pharmaceuticals's earnings are forecast to decrease from -$2.56 per share to -$1.93 per share next year representing a decrease of -35.88%.
CASI Pharmaceuticals's next earnings date is August 20, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.